TraceLink company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former TraceLink executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Products & Services
Track and trace
Description: Solutions focused on pharmaceutical industry serialization and traceability to help customers meet regulatory compliance requirements suc• •• •• ••• ••• •••••.••••: •••••• •••••• ••••••••, •••••••• ••••••••• •••••••••••• •••••• (••••), ••••••• ••••••••••••, •••••••••• •••••••••• •••••••, •••••••••••••, •••••• •••••• •••••••, ••••••• ••••••••••••• ••••: •••• •• •••••••••••••• •••••••••, ••••••••••••, ••• •••••••••• ••••••••• ••• •••••• •••••••••••••, •••••••••• ••••••••••, ••••-••••••••••••••, ••• ••••••• •••••••••••••• •• •••• •••••-•••-••••• ••••••••••• ••••••••: •••••• •••••• •••••••••• ••• ••••••••••, •••••••••••/••-•••••••••••, •••••••••• •••••••••, •••••••••• •••••••••, ••••••• ••••••••••••••, •••••• •••• ••••••••
Supply chain orchestration
Description: Network-enabled platform solutions for multienterprise collaboration and supply chain automation that TraceLink is adding to drive future ••••••.••••: ••••••• ••••••••••••• ••• ••••••••• ••••• (••••), ••••••••••••••• ••••••••••• ••••••• ••••• (••••), •••• ••••••• ••••••• ••••••••, ••••••• •••••••••••••••• ••••: •••• •• •••• •••••••• •••••••••••••, ••••••••••••, ••• ••••••• •••••••• ••• ••••••• •••••••••••••, ••••••••• •••••••• •••••••••, ••••••••• ••••••••••, ••• •••-••-••• •••••• ••••• •••••••••••••••• ••••••••: ••••-•••• •••• ••••••••, •••••••• ••••••••••, ••••••••• ••••••••, ••••••••• ••• ••••••••••, ••••••• •••••••, ••••••• ••••••••••, ••••••••• ••••••••••
Pricing & Go-to-market
Typical Contract Length
••-••••• ••••••••• •••••••••••••, •••••••• ••••••••
Pricing model
Tiered pricing structure that varies based on company size with a variable component tied to the number of serial numbers issued. Pharmaceutical compa•••• ••• ••• ••••••• ••••••, •••••••••••• ••• ••••, ••• •••••••••• ••••••••• ••• ••• •••••. ••• •••• •••••••• •••• •••-•••• ••••••• •••• ••••••••• •••••••••• •• $•••, •••••••• •••••••••• •• $•,•••, ••• •••• •••••••••• •• $•,••• ••••••••
Average Sales Value
Large pharma contracts typically range $200,000-$300,000 annually, average pharma clients around $100,000 annually, and healthcare customers range fro• $•,••• •• $•••,••• ••••••••
Growth Review
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 TraceLink | $1••m '•• | •,••• '•• | - | USA | P•••••••• |
 Antares Vision Group | Life Science | - | - | ••••••••• ••• ••••••• •••••• ••••••• •• ••• ••••••••••• •••••• ••• •••••••••••••• ••••• ••• ••••• ••... | - | P••••• |
 Antares Vision Group | Supply Chain | - | - | ••••••••• ••• •••••• ••••••• ••••••• •• ••• •••••••••••••• ••••• ••• ••••• ••••••, •••• •••••• •••••... | - | P••••• |
 SAP | - | - | ••••••••• ••• ••• ••••••• ••••••• •• ••• •••••• ••••• ••• ••••• ••••••, •••• ••••••••• •••••••• •• •... | - | P••••• |
 OPTEL Group | - | ••• '•• | ••••••••• ••••• • •••••••• •••••••• •• ••••• • •••••••••••••• ••••• ••• ••••• •••••••• •••• •••••• •... | Canada | F•••••••••••• |
Experts highlight TraceLink's operational execution and market approach, while noting regulatory complexity as a potential constraint.
What does Origin provide on TraceLink?
Origin provides a structured company snapshot of TraceLink, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of TraceLink different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how TraceLink operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like TraceLink?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like TraceLink for investment, partnership, or competitive analysis.
Where does Origin's information on TraceLink come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on TraceLink?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to TraceLink. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing TraceLink?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like TraceLink.
How can Origin support portfolio monitoring or add-on analysis for companies like TraceLink?
For PE-backed contexts, Origin can support monitoring by surfacing changes in competitive intensity, customer demand signals, and go-to-market effectiveness. It can also inform add-on analysis by clarifying adjacency opportunities and how a target like TraceLink may fit within a broader platform strategy.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like TraceLink?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like TraceLink, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
AIMA
Healthcare revenue cycle management solution for genetic testing companies and clinical providers to manage billing, coding, compliance, accounts receivable, and administrative operations.
HQ
Ownership
Fullscript
Healthcare ecommerce platform for practitioners in integrative and functional medicine to manage supplement prescribing, patient fulfillment, and treatment adherence.